Real-Life 2-Year Therapeutic Strategies in the Management of 525 Small-Cell Lung Cancers: The ESCAP Study Preliminary Results

被引:0
|
作者
Debieuvre, Didier [1 ]
Goupil, Francois [2 ]
Brun, Philippe [3 ]
Dixmier, Adrien [4 ]
De Faverges, Geoffroy [5 ]
Nocent-Ejnaini, Cecilia [6 ]
Crequit, Jacky [7 ]
Vuillermoz-Blas, Sylvie [8 ]
Perrin, Christophe [9 ]
Leleu, Olivier [10 ]
Carbonnelle, Michel [11 ]
Goutorbe, Frederic [12 ]
Asselain, Bernard [13 ]
Blanchon, Francois [14 ]
Martin, Francis [15 ]
Grivaux, Michel [14 ]
机构
[1] Emile Muller Gen Hosp, Mulhouse, France
[2] Ctr Hosp Mans, Le Mans, France
[3] Ctr Hosp Gen Valence, Valence, France
[4] Ctr Hosp Orleans, Orleans, France
[5] Hop Pierre Beregovoy, Nevers, France
[6] Ctr Hosp Cote Basque, Bayonne, France
[7] Ctr Hosp Laennec, Creil, France
[8] Ctr Hosp St Joseph St Luc, Lyon, France
[9] Ctr Hosp Cannes, Cannes, France
[10] Ctr Hosp Abbeville, Abbeville, France
[11] Hop Auban Moet, Epernay, France
[12] Ctr Hosp Gen Beziers, Beziers, France
[13] Inst Curie, Paris, France
[14] Ctr Hosp Meaux, Meaux, France
[15] Ctr Hosp Gen Compiegne, Compiegne, France
关键词
therapeutic strategies; small-cell lung cancers;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.07-013
引用
收藏
页码:S500 / S500
页数:1
相关论文
共 50 条
  • [1] Real-Life 2-Year Therapeutic Strategies in the Management of Metastatic Non-Small-Cell Lung Cancers: The ESCAP Study
    Debieuvre, Didier
    Goupil, Francois
    Lemaire, Bertrand
    Herman, Dominique
    Falchero, Lionel
    Renault, Patrick-Aldo
    Levy, Antoine
    Dumont, Patrick
    Paillot, Nadine
    Masson, Philippe
    Barriere, Jean-Renaud
    Duvall, Yannick
    Asselain, Bernard
    Blanchon, Francois
    Martin, Francis
    Grivaux, Michel
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S538 - S538
  • [2] Real-life 2-year therapeutic strategies in the management of 525 small-cell lung cancers (SCLCs) in French general hospitals.
    Debieuvre, Didier
    Goupil, Francois
    Brun, Philippe
    Diximier, Adrien
    De Faverges, Geoffroy
    Nocent-Ejnaini, Cecilia
    Crequit, Jacky
    Sylvie, Vuillermoz Blas
    Perrin, Christophe
    Leleu, Olivier
    Carbonnelle, Michel
    Asselain, Bernard
    Blanchon, Francois
    Martin, Francis
    Grivaux, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Real-life 2-year therapeutic strategies in the management of 2003 metastatic non-small-cell lung cancers (NSCLCs) in French general hospital.
    Debieuvre, Didier
    Goupil, Francois
    Lemaire, Bertrand
    Herman, Dominique
    Falchero, Lionel
    Renault, Patrick-Aldo
    Levy, Antoine
    Dumont, Patrick
    Paillot, Nadine
    Masson, Philippe
    Barriere, Jean-Renaud
    Duval, Yannick
    Asselain, Bernard
    Blanchon, Francois
    Martin, Francis
    Grivaux, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
    Shah-Hosseini, Kija
    Krudewig, Eva-Maria
    Hadler, Meike
    Karagiannis, Efstrathios
    Moesges, Ralph
    ADVANCES IN THERAPY, 2017, 34 (06) : 1382 - 1397
  • [5] Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
    Kija Shah-Hosseini
    Eva-Maria Krudewig
    Meike Hadler
    Efstrathios Karagiannis
    Ralph Mösges
    Advances in Therapy, 2017, 34 : 1382 - 1397
  • [6] Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study
    Di Bona, Danilo
    Nettis, Eustachio
    Minenna, Elena
    Lovecchio, Antonella
    Paolino, Donato
    Cristina Nizi, Maria
    Albanesi, Marcello
    Ridolo, Erminia
    Filomena Caiaffa, Maria
    Macchia, Luigi
    ALLERGY, 2020, 75 (10) : 2681 - 2684
  • [7] Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study
    Galluzzo, Marco
    Talamonti, Marina
    Atzori, Laura
    Bardazzi, Federico
    Campanati, Anna
    Di Cesare, Antonella
    Diotallevi, Federico
    Flori, Maria Laura
    Mugheddu, Cristina
    Offidani, Annamaria
    Piaserico, Stefano
    Russo, Filomena
    Sacchelli, Lidia
    Bianchi, Luca
    Prignano, Francesca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (04) : 547 - 554
  • [8] Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study
    Pieragostini, Remi
    Xhaard, Alienor
    Sauvageon, Helene
    Madelaine, Isabelle
    Touratier, Sophie
    Denis, Blandine
    MEDICAL MYCOLOGY, 2023, 61 (04)
  • [9] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
    Reis, D.
    Mendes, A.
    China, N.
    Dias, M.
    Coutinho, D.
    Silva, E.
    Campainha, S.
    Costa, T.
    Conde, S.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S975 - S976
  • [10] Real-life second-line epirubicin-paclitaxel regimen as treatment of relapsed small-cell lung cancer: EpiTax study
    Annic, Josselin
    Babey, Helene
    Corre, Romain
    Descourt, Renaud
    Quere, Gilles
    Renaud, Emmanuelle
    Lambert, Mickael
    Le Noac'h, Pierre
    Dhamelincourt, Estelle
    Nguyen, Jessica
    Vu, Alicia
    Bourbonne, Vincent
    Robinet, Gilles
    Geier, Margaux
    CANCER MEDICINE, 2023, 12 (03): : 2658 - 2665